A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

This study has been completed.

Study NCT00644176 Information provided by Pfizer

First Received: March 19, 2008 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2005
Estimated Primary Completion Date:	No date given